BRIVARACETAM

BRIVARACETAM was reported 9327 times

BRIVARACETAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 JC POLYOMAVIRUS TEST 8 0.5333
1 HYPOKINETIC DYSARTHRIA 15 0.5000
2 EPILEPSY SURGERY 12 0.4800
3 BROMODERMA 4 0.4000
4 NEW ONSET REFRACTORY STATUS EPILEPTICUS 33 0.3000
5 AUTOIMMUNE APLASTIC ANAEMIA 4 0.2857
6 MATERNAL DEATH 8 0.2581
7 GENERALISED ONSET NON-MOTOR SEIZURE 7 0.2121
8 SEVERE MYOCLONIC EPILEPSY OF INFANCY 6 0.1935
9 EPILEPSIA PARTIALIS CONTINUA 8 0.1905
10 AUTOMATISM EPILEPTIC 5 0.1389
11 INTESTINAL ATRESIA 14 0.1296
12 CORPUS CALLOSOTOMY 4 0.1250
13 VAGAL NERVE STIMULATOR IMPLANTATION 36 0.1176
14 ABERRANT AORTIC ARCH 5 0.1087
15 DISRUPTIVE MOOD DYSREGULATION DISORDER 8 0.1081
16 POST STROKE DEPRESSION 4 0.1053
17 JUVENILE MYOCLONIC EPILEPSY 6 0.0952
18 POSTICTAL PARALYSIS 23 0.0950
19 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 37 0.0791
20 SEIZURE CLUSTER 65 0.0784
21 NEUROPROSTHESIS IMPLANTATION 10 0.0719
22 POSTICTAL PSYCHOSIS 11 0.0705
23 MULTIPLE-DRUG RESISTANCE 218 0.0702
24 CONGENITAL MUSCULOSKELETAL DISORDER OF SKULL 5 0.0694
25 CHANGE IN SEIZURE PRESENTATION 43 0.0665
26 FOCAL DYSCOGNITIVE SEIZURES 73 0.0641
27 BLOOD KETONE BODY DECREASED 3 0.0638
28 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 34 0.0636
29 LEUKOPLAKIA 15 0.0612
30 UMBILICAL HAEMORRHAGE 9 0.0596
31 ATONIC SEIZURES 45 0.0524
32 MEDICAL DEVICE BATTERY REPLACEMENT 7 0.0519
33 CORTICAL DYSPLASIA 3 0.0508
34 VENTRICULO-PERITONEAL SHUNT 5 0.0439
35 PULMONARY HAEMORRHAGE NEONATAL 4 0.0435
36 SEPARATION ANXIETY DISORDER 5 0.0420
37 PARTIAL SEIZURES 210 0.0401
38 AURA 74 0.0396
39 PALINDROMIC RHEUMATISM 6 0.0377
40 SIDEROBLASTIC ANAEMIA 5 0.0357
41 LENNOX-GASTAUT SYNDROME 8 0.0352
42 TONIC CONVULSION 48 0.0339
43 PETIT MAL EPILEPSY 161 0.0315
44 BRAIN OPERATION 70 0.0306
45 DEJA VU 8 0.0291
46 SEIZURE 3353 0.0290
47 PSYCHOGENIC SEIZURE 27 0.0289
48 DYSPRAXIA 16 0.0284
49 MYOCLONIC EPILEPSY 43 0.0283
50 LESION EXCISION 4 0.0282
51 CENTRAL SLEEP APNOEA SYNDROME 8 0.0246
52 SIMPLE PARTIAL SEIZURES 19 0.0235
53 BEHAVIOUR DISORDER 127 0.0235
54 DRUG CLEARANCE INCREASED 5 0.0224
55 ECG SIGNS OF MYOCARDIAL ISCHAEMIA 5 0.0219
56 GENERALISED TONIC-CLONIC SEIZURE 360 0.0217
57 VESTIBULAR MIGRAINE 5 0.0207
58 OROMANDIBULAR DYSTONIA 15 0.0206
59 STATUS EPILEPTICUS 231 0.0204
60 DRUG LEVEL FLUCTUATING 18 0.0203
61 SELF-DESTRUCTIVE BEHAVIOUR 17 0.0195
62 GINGIVITIS ULCERATIVE 4 0.0186
63 ANTICONVULSANT DRUG LEVEL INCREASED 30 0.0186
64 HALLUCINATION, OLFACTORY 8 0.0184
65 PRODUCT AVAILABILITY ISSUE 403 0.0177
66 KIDNEY SMALL 5 0.0171
67 GASTROSCHISIS 8 0.0168
68 MITRAL VALVE THICKENING 5 0.0168
69 INTELLECTUAL DISABILITY 24 0.0158
70 EPILEPTIC AURA 4 0.0155
71 SLEEP DEFICIT 31 0.0147
72 AMNESTIC DISORDER 7 0.0144
73 AUTOMATISM 3 0.0139
74 MIXED ANXIETY AND DEPRESSIVE DISORDER 5 0.0135
75 HYPERAMMONAEMIC ENCEPHALOPATHY 23 0.0132
76 COVID-19 IMMUNISATION 11 0.0132
77 GAZE PALSY 22 0.0129
78 PROPOFOL INFUSION SYNDROME 9 0.0128
79 INABILITY TO AFFORD MEDICATION 125 0.0126
80 DUPLICATE THERAPY ERROR 4 0.0125
81 CRANIOTOMY 5 0.0122
82 PRODUCT DISPENSING ISSUE 52 0.0121
83 MEDICAL INDUCTION OF COMA 5 0.0118
84 EPILEPSY 352 0.0115
85 LIP INJURY 15 0.0114
86 MATERNAL EXPOSURE BEFORE PREGNANCY 76 0.0111
87 FEEDING TUBE USER 4 0.0109
88 INTERNAL FIXATION OF FRACTURE 6 0.0105
89 HAEMANGIOMA CONGENITAL 5 0.0105
90 INSURANCE ISSUE 149 0.0097
91 SUSPICIOUSNESS 6 0.0085
92 ACIDOSIS HYPERCHLORAEMIC 5 0.0084
93 GASTROSTOMY 13 0.0084
94 CARDIAC SEPTAL DEFECT 6 0.0083
95 ANISOCORIA 3 0.0079
96 POSTICTAL STATE 8 0.0077
97 THERAPY INTERRUPTED 545 0.0076
98 ENCEPHALITIS AUTOIMMUNE 10 0.0076
99 ASTROCYTOMA 3 0.0076
100 PULMONARY VALVE INCOMPETENCE 11 0.0075
101 STARING 18 0.0074
102 DEATH OF RELATIVE 3 0.0074
103 AFFECTIVE DISORDER 58 0.0074
104 ATAXIA 86 0.0072
105 PRODUCT DISTRIBUTION ISSUE 65 0.0070
106 CARBON MONOXIDE POISONING 3 0.0070
107 BULIMIA NERVOSA 3 0.0068
108 DRUG WITHDRAWAL CONVULSIONS 12 0.0067
109 DROP ATTACKS 4 0.0067
110 HEPATORENAL FAILURE 4 0.0066
111 MATERNAL EXPOSURE DURING BREAST FEEDING 26 0.0064
112 STEREOTYPY 6 0.0064
113 PRODUCT CONTAINER SEAL ISSUE 11 0.0063
114 LIP HAEMORRHAGE 8 0.0063
115 MUTISM 9 0.0062
116 AGGRESSION 310 0.0062
117 HYPERMAGNESAEMIA 4 0.0061
118 VACCINATION COMPLICATION 5 0.0061
119 ELECTROENCEPHALOGRAM ABNORMAL 19 0.0060
120 NONINFECTIVE ENCEPHALITIS 4 0.0056
121 CLONIC CONVULSION 4 0.0055
122 AORTIC DILATATION 6 0.0054
123 FACIAL SPASM 6 0.0054
124 MYOCLONUS 63 0.0053
125 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 14 0.0053
126 TRACHEITIS 4 0.0052
127 CEREBELLAR ATAXIA 5 0.0052
128 ENANTHEMA 3 0.0052
129 FEELING DRUNK 38 0.0051
130 PRODUCT INEFFECTIVE 4 0.0051
131 HEAD TITUBATION 7 0.0051
132 IMPULSIVE BEHAVIOUR 19 0.0051
133 TUMOUR EXCISION 4 0.0050
134 PRESCRIBED OVERDOSE 96 0.0050
135 NYSTAGMUS 26 0.0049
136 TONGUE BITING 10 0.0048
137 CIRCADIAN RHYTHM SLEEP DISORDER 4 0.0048
138 TRICUSPID VALVE INCOMPETENCE 38 0.0048
139 GLIOBLASTOMA MULTIFORME 4 0.0048
140 APRAXIA 7 0.0047
141 APTYALISM 4 0.0047
142 CRANIOFACIAL FRACTURE 4 0.0047
143 HYDROCEPHALUS 25 0.0046
144 FOOD REFUSAL 4 0.0046
145 HYPERTROPHIC CARDIOMYOPATHY 7 0.0045
146 CRYPTORCHISM 5 0.0045
147 PARADOXICAL DRUG REACTION 16 0.0043
148 BODY TEMPERATURE FLUCTUATION 9 0.0043
149 GLOSSITIS 15 0.0042
150 MECHANICAL VENTILATION 8 0.0042
151 TRACHEOSTOMY 6 0.0042
152 HYPERAMMONAEMIA 21 0.0042
153 MOOD SWINGS 133 0.0042
154 BITE 3 0.0041
155 BLOOD FOLATE DECREASED 3 0.0041
156 FEBRILE CONVULSION 5 0.0041
157 ANGER 135 0.0040
158 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 3 0.0040
159 PSYCHIATRIC SYMPTOM 29 0.0039
160 SEDATION COMPLICATION 10 0.0039
161 HYPERSEXUALITY 7 0.0038
162 IRRITABILITY 229 0.0038
163 PATENT DUCTUS ARTERIOSUS 15 0.0038
164 AORTIC VALVE INCOMPETENCE 16 0.0038
165 BINGE EATING 4 0.0037
166 SKULL FRACTURE 6 0.0037
167 RIGHT VENTRICULAR DYSFUNCTION 4 0.0036
168 IGA NEPHROPATHY 6 0.0036
169 SALIVARY HYPERSECRETION 36 0.0036
170 ECHOCARDIOGRAM ABNORMAL 5 0.0036
171 ANTICONVULSANT DRUG LEVEL DECREASED 5 0.0035
172 HYPERNATRAEMIA 17 0.0034
173 COMMUNICATION DISORDER 13 0.0034
174 DIPLOPIA 86 0.0033
175 METAMORPHOPSIA 6 0.0033
176 DAYDREAMING 5 0.0032
177 ENDOTRACHEAL INTUBATION 9 0.0032
178 MEDICAL DEVICE IMPLANTATION 5 0.0032
179 BRAIN NEOPLASM 29 0.0032
180 HEPATOSPLENOMEGALY 8 0.0031
181 APGAR SCORE LOW 4 0.0031
182 DRUG TITRATION ERROR 8 0.0031
183 SLOW RESPONSE TO STIMULI 4 0.0031
184 MATERNAL EXPOSURE DURING PREGNANCY 275 0.0031
185 SHOULDER FRACTURE 5 0.0031
186 SPINAL CORD DISORDER 5 0.0030
187 HIRSUTISM 4 0.0030
188 ANXIETY DISORDER 10 0.0030
189 CRANIOCEREBRAL INJURY 9 0.0030
190 ENURESIS 12 0.0030
191 DROWNING 3 0.0030
192 PERSONALITY CHANGE 27 0.0029
193 DROOLING 20 0.0029
194 ALOPECIA AREATA 5 0.0028
195 ALVEOLITIS 4 0.0028
196 FANCONI SYNDROME 4 0.0028
197 SEDATION 73 0.0028
198 MONOPARESIS 5 0.0028
199 DYSPHEMIA 12 0.0027
200 WRONG PATIENT RECEIVED PRODUCT 8 0.0027
201 DRUG LEVEL BELOW THERAPEUTIC 15 0.0027
202 CONCUSSION 21 0.0027
203 ESSENTIAL TREMOR 3 0.0027
204 BRAIN NEOPLASM MALIGNANT 12 0.0027
205 COGNITIVE DISORDER 125 0.0027
206 PRODUCT ADMINISTRATION INTERRUPTED 21 0.0027
207 PRODUCT SUPPLY ISSUE 19 0.0027
208 SOMNOLENCE 532 0.0026
209 MOOD ALTERED 72 0.0026
210 GINGIVAL HYPERTROPHY 4 0.0026
211 FACE INJURY 10 0.0026
212 HYPERSOMNIA 75 0.0026
213 PNEUMONIA PSEUDOMONAL 4 0.0026
214 FOLATE DEFICIENCY 3 0.0026
215 CLEFT PALATE 5 0.0026
216 POLYCYSTIC OVARIES 4 0.0026
217 NORMAL NEWBORN 14 0.0026
218 CEREBRAL DISORDER 19 0.0026
219 JOINT NOISE 5 0.0025
220 BLOOD PROLACTIN INCREASED 12 0.0025
221 INAPPROPRIATE AFFECT 4 0.0025
222 ACUTE PSYCHOSIS 6 0.0024
223 HYPERACUSIS 9 0.0024
224 DYSPNOEA AT REST 7 0.0024
225 EDUCATIONAL PROBLEM 4 0.0024
226 SUICIDAL IDEATION 220 0.0024
227 OVERDOSE 516 0.0024
228 ATTENTION DEFICIT HYPERACTIVITY DISORDER 10 0.0024
229 AUTISM SPECTRUM DISORDER 13 0.0024
230 ABNORMAL BEHAVIOUR 93 0.0023
231 GLIOBLASTOMA 4 0.0023
232 LAZINESS 4 0.0023
233 HEAD INJURY 74 0.0023
234 REHABILITATION THERAPY 9 0.0023
235 PRODUCT PACKAGING DIFFICULT TO OPEN 6 0.0023
236 BRADYPHRENIA 15 0.0023
237 HEMIPLEGIA 19 0.0023
238 HALLUCINATION, AUDITORY 36 0.0023
239 APATHY 33 0.0023
240 PARKINSONISM 22 0.0023
241 MUSCLE TWITCHING 52 0.0023
242 SCHIZOAFFECTIVE DISORDER 4 0.0022
243 PSYCHOMOTOR HYPERACTIVITY 37 0.0022
244 HOMICIDAL IDEATION 9 0.0022
245 TIC 12 0.0022
246 PREMATURE DELIVERY 35 0.0022
247 READING DISORDER 5 0.0022
248 DRUG RESISTANCE 56 0.0022
249 PSYCHOTIC DISORDER 64 0.0022
250 BLOOD BICARBONATE DECREASED 4 0.0021
251 RADIOTHERAPY 4 0.0021
252 GINGIVAL DISORDER 8 0.0021
253 HICCUPS 17 0.0021
254 DYSARTHRIA 77 0.0020
255 ANKLE OPERATION 3 0.0020
256 EXCESSIVE EYE BLINKING 3 0.0020
257 CEREBRAL ATROPHY 8 0.0020
258 GASTROINTESTINAL TUBE INSERTION 5 0.0020
259 DEPRESSIVE SYMPTOM 7 0.0020
260 URINARY TRACT INFECTION BACTERIAL 5 0.0020
261 CAESAREAN SECTION 23 0.0020
262 IMPULSE-CONTROL DISORDER 4 0.0019
263 DRUG LEVEL INCREASED 32 0.0019
264 INTENTIONAL SELF-INJURY 39 0.0019
265 PERFORMANCE STATUS DECREASED 9 0.0019
266 SUICIDAL BEHAVIOUR 8 0.0019
267 PHYSICAL ASSAULT 4 0.0019
268 WALKING DISABILITY 4 0.0019
269 SELF-INJURIOUS IDEATION 8 0.0019
270 SKIN ABRASION 9 0.0019
271 EYE CONTUSION 4 0.0019
272 HYPERKINESIA 4 0.0019
273 BALANCE DISORDER 163 0.0019
274 SCREAMING 12 0.0019
275 AFFECT LABILITY 18 0.0019
276 MITRAL VALVE INCOMPETENCE 21 0.0019
277 APHASIA 56 0.0019
278 SPEECH DISORDER 97 0.0018
279 CLUMSINESS 5 0.0018
280 LISTLESS 6 0.0018
281 ARTHROPOD STING 3 0.0018
282 BRAIN INJURY 18 0.0018
283 PSYCHOMOTOR RETARDATION 5 0.0018
284 WRONG PRODUCT ADMINISTERED 12 0.0018
285 DEAFNESS BILATERAL 3 0.0018
286 EXPOSURE VIA BREAST MILK 7 0.0018
287 CHOREA 3 0.0017
288 SPINAL FUSION SURGERY 7 0.0017
289 THINKING ABNORMAL 32 0.0017
290 HALLUCINATION, VISUAL 36 0.0017
291 LOGORRHOEA 6 0.0017
292 PRODUCT USE ISSUE 320 0.0017
293 DISTURBANCE IN SOCIAL BEHAVIOUR 4 0.0017
294 FACIAL PARESIS 6 0.0017
295 AGITATION 124 0.0017
296 GESTATIONAL DIABETES 8 0.0017
297 SUBCUTANEOUS ABSCESS 8 0.0017
298 FACIAL BONES FRACTURE 6 0.0017
299 WEIGHT ABNORMAL 4 0.0017
300 SLEEP TERROR 7 0.0017
301 MEMORY IMPAIRMENT 227 0.0017
302 VITAMIN D DEFICIENCY 16 0.0016
303 BLOOD THYROID STIMULATING HORMONE ABNORMAL 3 0.0016
304 DEPRESSED MOOD 86 0.0016
305 ECTOPIC PREGNANCY 5 0.0016
306 RESTLESSNESS 59 0.0016
307 PRODUCT PRESCRIBING ISSUE 35 0.0016
308 HOSTILITY 4 0.0016
309 AMMONIA INCREASED 8 0.0016
310 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
311 EMOTIONAL DISORDER 48 0.0016
312 HERNIA REPAIR 4 0.0015
313 MENTAL DISORDER 67 0.0015
314 PULMONARY HAEMORRHAGE 12 0.0015
315 PERSONALITY DISORDER 4 0.0015
316 PRODUCT PREPARATION ISSUE 10 0.0015
317 ERECTILE DYSFUNCTION 39 0.0015
318 CATARACT OPERATION 9 0.0015
319 APHONIA 21 0.0015
320 HIP SURGERY 8 0.0015
321 PRODUCT PACKAGING ISSUE 14 0.0015
322 MIGRAINE WITH AURA 4 0.0015
323 SKIN LACERATION 16 0.0015
324 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 13 0.0015
325 CHOLANGITIS SCLEROSING 3 0.0015
326 DISTURBANCE IN ATTENTION 78 0.0014
327 DEPRESSION SUICIDAL 5 0.0014
328 ALTERED STATE OF CONSCIOUSNESS 31 0.0014
329 ABORTION SPONTANEOUS 57 0.0014
330 NEONATAL RESPIRATORY DISTRESS SYNDROME 5 0.0014
331 BRAIN FOG 22 0.0014
332 DEREALISATION 3 0.0014
333 PARANOIA 24 0.0014
334 EYELID MARGIN CRUSTING 4 0.0014
335 PANIC ATTACK 50 0.0014
336 OFF LABEL USE 1195 0.0014
337 PREMATURE BABY 41 0.0014
338 SLEEP DISORDER 96 0.0014
339 ENCEPHALOPATHY 33 0.0013
340 GASTROINTESTINAL HYPOMOTILITY 3 0.0013
341 SNORING 5 0.0013
342 EYE MOVEMENT DISORDER 9 0.0013
343 HALLUCINATION 98 0.0013
344 OESOPHAGEAL DISORDER 5 0.0013
345 AMNESIA 84 0.0013
346 FEELING OF DESPAIR 6 0.0013
347 LETHARGY 73 0.0013
348 POLYDIPSIA 5 0.0013
349 DEPRESSION 287 0.0013
350 HYPONATRAEMIA 71 0.0013
351 INTENTIONAL PRODUCT MISUSE 110 0.0013
352 IMPAIRED DRIVING ABILITY 14 0.0012
353 MAJOR DEPRESSION 9 0.0012
354 ANKLE FRACTURE 19 0.0012
355 SOCIAL AVOIDANT BEHAVIOUR 7 0.0012
356 POOR QUALITY SLEEP 26 0.0012
357 METABOLIC DISORDER 7 0.0012
358 TREMOR 200 0.0012
359 HYPERTRIGLYCERIDAEMIA 7 0.0012
360 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 85 0.0012
361 POST-TRAUMATIC STRESS DISORDER 8 0.0012
362 ASPIRATION 13 0.0012
363 PRODUCT DOSE OMISSION ISSUE 349 0.0012
364 DYSTONIA 23 0.0012
365 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 65 0.0012
366 ADVERSE DRUG REACTION 106 0.0012
367 NEPHROPATHY 11 0.0012
368 HOSPITALISATION 181 0.0012
369 SHOULDER OPERATION 5 0.0012
370 LEFT VENTRICULAR HYPERTROPHY 5 0.0012
371 WRIST FRACTURE 14 0.0012
372 DEPRESSED LEVEL OF CONSCIOUSNESS 46 0.0012
373 TEARFULNESS 5 0.0012
374 PRIAPISM 4 0.0012
375 FALL 381 0.0011
376 DRUG INTERACTION 181 0.0011
377 SEASONAL ALLERGY 16 0.0011
378 HAND FRACTURE 8 0.0011
379 THERMAL BURN 8 0.0011
380 EATING DISORDER 24 0.0011
381 HEMIPARESIS 19 0.0011
382 ILEUS PARALYTIC 5 0.0011
383 DRUG INTOLERANCE 108 0.0011
384 OVERWEIGHT 6 0.0011
385 INCREASED APPETITE 21 0.0011
386 DRUG LEVEL DECREASED 11 0.0011
387 MOTOR DYSFUNCTION 11 0.0011
388 COORDINATION ABNORMAL 15 0.0011
389 LEUKOENCEPHALOPATHY 4 0.0011
390 HEAD DISCOMFORT 19 0.0011
391 CEREBRAL THROMBOSIS 3 0.0011
392 CHEMOTHERAPY 4 0.0011
393 CLAVICLE FRACTURE 4 0.0010
394 PNEUMONIA ASPIRATION 26 0.0010
395 JOINT DISLOCATION 11 0.0010
396 STILLBIRTH 5 0.0010
397 THERAPEUTIC PRODUCT INEFFECTIVE 4 0.0010
398 MANIA 17 0.0010
399 ABORTION 3 0.0010
400 RHINOVIRUS INFECTION 4 0.0010
401 URINE ODOUR ABNORMAL 6 0.0010
402 URINARY INCONTINENCE 30 0.0010
403 HOSPICE CARE 10 0.0010
404 ENCEPHALITIS 7 0.0010
405 SMALL FOR DATES BABY 5 0.0010
406 LOW BIRTH WEIGHT BABY 8 0.0010
407 HYPERTRANSAMINASAEMIA 7 0.0010
408 ANEURYSM 5 0.0010
409 BRAIN HERNIATION 3 0.0010
410 GASTROENTERITIS VIRAL 18 0.0010
411 ANXIETY 283 0.0010
412 DRUG TOLERANCE 5 0.0010
413 PRODUCT USE IN UNAPPROVED INDICATION 243 0.0010
414 THERAPY NON-RESPONDER 44 0.0010
415 INITIAL INSOMNIA 10 0.0010
416 REBOUND EFFECT 11 0.0010
417 VISUAL FIELD DEFECT 7 0.0010
418 SCOLIOSIS 6 0.0010
419 FAMILY STRESS 3 0.0010
420 SOCIAL PROBLEM 4 0.0010
421 MIDDLE INSOMNIA 18 0.0010
422 DIZZINESS 479 0.0010
423 COAGULOPATHY 16 0.0010
424 PRODUCT TASTE ABNORMAL 13 0.0010
425 LIMB INJURY 26 0.0010
426 POISONING DELIBERATE 9 0.0009
427 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
428 UNDERDOSE 69 0.0009
429 LIP OEDEMA 4 0.0009
430 LEARNING DISABILITY 5 0.0009
431 EXPOSURE TO TOXIC AGENT 3 0.0009
432 FEEDING DISORDER 19 0.0009
433 CONFUSIONAL STATE 151 0.0009
434 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 7 0.0009
435 TREATMENT NONCOMPLIANCE 51 0.0009
436 LOSS OF CONSCIOUSNESS 119 0.0009
437 SUICIDE ATTEMPT 56 0.0009
438 RESPIRATORY SYNCYTIAL VIRUS INFECTION 8 0.0009
439 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 186 0.0009
440 BEDRIDDEN 12 0.0009
441 INTENTIONAL DOSE OMISSION 26 0.0009
442 WALKING AID USER 6 0.0009
443 INSOMNIA 242 0.0009
444 ROAD TRAFFIC ACCIDENT 38 0.0009
445 GINGIVAL SWELLING 4 0.0009
446 APPETITE DISORDER 6 0.0009
447 ADVERSE REACTION 12 0.0009
448 PHYSICAL DISABILITY 4 0.0009
449 MENINGITIS 6 0.0009
450 NIGHTMARE 31 0.0009
451 DEMENTIA 25 0.0009
452 PRODUCT USE COMPLAINT 14 0.0009
453 TARDIVE DYSKINESIA 25 0.0009
454 DISORIENTATION 35 0.0009
455 THERAPEUTIC PRODUCT EFFECT DELAYED 4 0.0009
456 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
457 MENTAL IMPAIRMENT 21 0.0009
458 HEPATIC CYTOLYSIS 11 0.0009
459 DYSKINESIA 35 0.0009
460 VERTIGO 52 0.0009
461 HYPOCALCAEMIA 16 0.0008
462 NERVOUSNESS 44 0.0008
463 APPENDICECTOMY 3 0.0008
464 COMA 40 0.0008
465 CARDIAC PACEMAKER INSERTION 5 0.0008
466 ACCIDENT 10 0.0008
467 DELUSION 13 0.0008
468 RASH VESICULAR 4 0.0008
469 THERAPEUTIC RESPONSE UNEXPECTED 37 0.0008
470 FEAR 22 0.0008
471 PRODUCT CONTAINER ISSUE 7 0.0008
472 CARDIAC OPERATION 7 0.0008
473 STEVENS-JOHNSON SYNDROME 18 0.0008
474 FOOT OPERATION 4 0.0008
475 HYSTERECTOMY 7 0.0008
476 DRUG INEFFECTIVE 1051 0.0008
477 BLOOD SODIUM DECREASED 15 0.0008
478 PHOTOPSIA 5 0.0008
479 SLUGGISHNESS 8 0.0008
480 FATIGUE 600 0.0008
481 VENTRICULAR EXTRASYSTOLES 8 0.0008
482 GAIT DISTURBANCE 145 0.0008
483 SURGERY 44 0.0007
484 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
485 ARTERIOSCLEROSIS 7 0.0007
486 FRUSTRATION TOLERANCE DECREASED 6 0.0007
487 NEUROTOXICITY 13 0.0007
488 BIPOLAR DISORDER 8 0.0007
489 DRUG ERUPTION 13 0.0007
490 CHOLESTASIS 14 0.0007
491 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 35 0.0007
492 CHOKING SENSATION 4 0.0007
493 TREATMENT FAILURE 60 0.0007
494 DECREASED APPETITE 168 0.0007
495 ATRIAL SEPTAL DEFECT 6 0.0007
496 MIGRAINE 68 0.0007
497 THERAPY CHANGE 7 0.0007
498 DISABILITY 14 0.0007
499 PRODUCT DOSE OMISSION 46 0.0007
500 PERONEAL NERVE PALSY 4 0.0007
501 FACIAL PARALYSIS 6 0.0007
502 CEREBRAL HAEMORRHAGE 25 0.0007
503 DELIRIUM 24 0.0007
504 CHAPPED LIPS 3 0.0007
505 STRESS CARDIOMYOPATHY 4 0.0007
506 SLEEP APNOEA SYNDROME 13 0.0007
507 NEPHROLITHIASIS 31 0.0007
508 HYPERBILIRUBINAEMIA 7 0.0007
509 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
510 PRODUCT PRESCRIBING ERROR 16 0.0007
511 RHABDOMYOLYSIS 28 0.0007
512 MULTIPLE ORGAN DYSFUNCTION SYNDROME 19 0.0007
513 DEVELOPMENTAL DELAY 6 0.0007
514 KNEE ARTHROPLASTY 14 0.0007
515 TYPE 1 DIABETES MELLITUS 4 0.0007
516 DYSPHAGIA 63 0.0007
517 SCRATCH 7 0.0007
518 FEELING ABNORMAL 159 0.0007
519 SCHIZOPHRENIA 8 0.0007
520 TENSION 4 0.0007
521 FOETAL EXPOSURE DURING PREGNANCY 53 0.0007
522 EYE OPERATION 3 0.0007
523 SKIN CANCER 14 0.0006
524 SPINAL FRACTURE 13 0.0006
525 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
526 ATRIOVENTRICULAR BLOCK 5 0.0006
527 BACK INJURY 7 0.0006
528 EXPOSURE DURING PREGNANCY 40 0.0006
529 APNOEA 5 0.0006
530 HAEMORRHAGIC STROKE 5 0.0006
531 INTENTIONAL PRODUCT USE ISSUE 56 0.0006
532 DRUG-INDUCED LIVER INJURY 20 0.0006
533 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
534 LEUKAEMIA 6 0.0006
535 INFUSION SITE SWELLING 4 0.0006
536 FOOT FRACTURE 12 0.0006
537 CRYING 23 0.0006
538 NEOPLASM PROGRESSION 22 0.0006
539 TRANSAMINASES INCREASED 14 0.0006
540 PARALYSIS 9 0.0006
541 GAIT INABILITY 21 0.0006
542 EOSINOPHILIA 11 0.0006
543 CHROMATURIA 14 0.0006
544 HYPOKINESIA 9 0.0006
545 ADVERSE EVENT 57 0.0006
546 HYPERPROLACTINAEMIA 4 0.0006
547 FEELING COLD 17 0.0006
548 KNEE OPERATION 6 0.0006
549 HYPOGAMMAGLOBULINAEMIA 4 0.0006
550 IMPAIRED WORK ABILITY 13 0.0006
551 UPPER LIMB FRACTURE 12 0.0006
552 ILLNESS 62 0.0006
553 PRODUCT DISPENSING ERROR 13 0.0006
554 MOVEMENT DISORDER 19 0.0006
555 WEIGHT INCREASED 132 0.0006
556 MACULAR DEGENERATION 7 0.0006
557 EUPHORIC MOOD 6 0.0006
558 VISION BLURRED 80 0.0006
559 RESPIRATION ABNORMAL 4 0.0006
560 THERAPY PARTIAL RESPONDER 9 0.0006
561 WEIGHT DECREASED 160 0.0006
562 SPINAL OPERATION 7 0.0006
563 INCONTINENCE 6 0.0006
564 BRONCHOSPASM 8 0.0006
565 FOOD POISONING 3 0.0006
566 NEUTROPENIC SEPSIS 4 0.0006
567 BRUXISM 3 0.0006
568 BRAIN OEDEMA 7 0.0006
569 LUPUS-LIKE SYNDROME 5 0.0006
570 PULMONARY THROMBOSIS 6 0.0005
571 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
572 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
573 TOOTH FRACTURE 6 0.0005
574 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 14 0.0005
575 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 98 0.0005
576 NEPHROPATHY TOXIC 6 0.0005
577 HYPOAESTHESIA ORAL 8 0.0005
578 INTENTIONAL OVERDOSE 34 0.0005
579 SARS-COV-2 TEST POSITIVE 7 0.0005
580 CONTUSION 51 0.0005
581 CONDITION AGGRAVATED 161 0.0005
582 HIP FRACTURE 17 0.0005
583 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
584 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
585 LIPASE INCREASED 4 0.0005
586 NEOPLASM 6 0.0005
587 SYNCOPE 52 0.0005
588 LIMB DISCOMFORT 16 0.0005
589 ENERGY INCREASED 3 0.0005
590 BRADYKINESIA 3 0.0005
591 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
592 NASAL DISCOMFORT 4 0.0005
593 MENTAL STATUS CHANGES 14 0.0005
594 PRODUCT SUBSTITUTION ISSUE 29 0.0005
595 HYPOMAGNESAEMIA 7 0.0005
596 HEADACHE 315 0.0005
597 PRESCRIBED UNDERDOSE 10 0.0005
598 HYPOTONIA 5 0.0005
599 DYSPHONIA 29 0.0005
600 MYASTHENIA GRAVIS 4 0.0005
601 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
602 NOCTURIA 6 0.0005
603 FOETAL GROWTH RESTRICTION 3 0.0005
604 SUBARACHNOID HAEMORRHAGE 5 0.0005
605 DECUBITUS ULCER 4 0.0005
606 SUBDURAL HAEMATOMA 7 0.0005
607 EAR INFECTION 13 0.0005
608 PHOTOSENSITIVITY REACTION 8 0.0005
609 MENSTRUAL DISORDER 4 0.0005
610 BACTERIAL INFECTION 9 0.0005
611 GASTROINTESTINAL DISORDER 43 0.0005
612 PETECHIAE 5 0.0005
613 UNINTENDED PREGNANCY 5 0.0005
614 WEIGHT FLUCTUATION 5 0.0005
615 BLEPHAROSPASM 3 0.0005
616 ABNORMAL DREAMS 13 0.0005
617 CARDIAC FLUTTER 3 0.0005
618 DECREASED ACTIVITY 5 0.0005
619 CEREBROVASCULAR ACCIDENT 78 0.0005
620 INCORRECT DOSE ADMINISTERED 105 0.0005
621 ORTHOSTATIC HYPOTENSION 8 0.0005
622 JOINT STIFFNESS 12 0.0005
623 URINARY TRACT INFECTION 78 0.0005
624 DYSGRAPHIA 3 0.0005
625 HYPOXIA 16 0.0005
626 COVID-19 79 0.0004
627 PREGNANCY 9 0.0004
628 MENINGIOMA 7 0.0004
629 THERAPY CESSATION 23 0.0004
630 MALNUTRITION 5 0.0004
631 PRODUCT ADMINISTRATION ERROR 9 0.0004
632 DERMATITIS CONTACT 5 0.0004
633 METABOLIC ACIDOSIS 14 0.0004
634 RIB FRACTURE 9 0.0004
635 SKIN LESION 12 0.0004
636 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
637 NO ADVERSE EVENT 79 0.0004
638 VOMITING 205 0.0004
639 BRADYCARDIA 23 0.0004
640 NERVE COMPRESSION 4 0.0004
641 PERICARDIAL EFFUSION 10 0.0004
642 DRY MOUTH 35 0.0004
643 ELECTROLYTE IMBALANCE 5 0.0004
644 ANGIOEDEMA 19 0.0004
645 RASH 187 0.0004
646 VISUAL IMPAIRMENT 53 0.0004
647 PHOTOPHOBIA 8 0.0004
648 ABORTION INDUCED 4 0.0004
649 COVID-19 PNEUMONIA 5 0.0004
650 RESPIRATORY TRACT INFECTION 11 0.0004
651 BACTERAEMIA 5 0.0004
652 THROMBOCYTOPENIA 47 0.0004
653 MUSCLE RIGIDITY 5 0.0004
654 POLYNEUROPATHY 5 0.0004
655 LOWER LIMB FRACTURE 8 0.0004
656 TINNITUS 19 0.0004
657 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
658 ACCIDENTAL OVERDOSE 15 0.0004
659 BODY TEMPERATURE DECREASED 4 0.0004
660 ARTHROPOD BITE 3 0.0004
661 LIGAMENT SPRAIN 4 0.0004
662 PHARYNGITIS 5 0.0004
663 LEUKOPENIA 20 0.0004
664 RESPIRATORY ARREST 11 0.0004
665 TASTE DISORDER 8 0.0004
666 DISSOCIATION 3 0.0004
667 ORAL CANDIDIASIS 5 0.0004
668 THERAPEUTIC RESPONSE DECREASED 23 0.0004
669 MEDICATION ERROR 21 0.0004
670 PNEUMONIA 122 0.0004
671 OBESITY 6 0.0004
672 HEPATIC STEATOSIS 7 0.0004
673 PANCYTOPENIA 21 0.0004
674 ASTHENIA 141 0.0004
675 LIVER FUNCTION TEST INCREASED 8 0.0004
676 HYPERSENSITIVITY 69 0.0004
677 MUSCLE TIGHTNESS 6 0.0004
678 HEART RATE DECREASED 13 0.0004
679 INJURY 26 0.0004
680 PHARYNGITIS STREPTOCOCCAL 4 0.0004
681 RASH PRURITIC 20 0.0004
682 POST PROCEDURAL COMPLICATION 7 0.0004
683 ACUTE RESPIRATORY FAILURE 7 0.0004
684 GASTROINTESTINAL PAIN 4 0.0004
685 CARDIAC ARREST 30 0.0004
686 RESPIRATORY DISTRESS 10 0.0004
687 CONSTIPATION 79 0.0004
688 DENTAL CARIES 4 0.0004
689 TACHYCARDIA 32 0.0004
690 HUNGER 5 0.0004
691 BLOOD PRESSURE SYSTOLIC INCREASED 7 0.0004
692 CHOKING 7 0.0004
693 MASS 5 0.0004
694 CARPAL TUNNEL SYNDROME 5 0.0004
695 HYPERGLYCAEMIA 13 0.0004
696 OCULAR DISCOMFORT 4 0.0004
697 MULTIPLE SCLEROSIS 17 0.0004
698 SINUS TACHYCARDIA 5 0.0004
699 HYPOPHAGIA 9 0.0004
700 ALOPECIA 69 0.0004
701 INTERNATIONAL NORMALISED RATIO INCREASED 10 0.0004
702 INTERNAL HAEMORRHAGE 4 0.0003
703 HAEMATOMA 9 0.0003
704 PARAESTHESIA ORAL 5 0.0003
705 MADAROSIS 4 0.0003
706 FLUID OVERLOAD 5 0.0003
707 PARAESTHESIA 54 0.0003
708 TOXICITY TO VARIOUS AGENTS 57 0.0003
709 TOOTH LOSS 7 0.0003
710 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
711 RASH ERYTHEMATOUS 16 0.0003
712 MUSCULAR WEAKNESS 38 0.0003
713 ANAL INCONTINENCE 3 0.0003
714 NAUSEA 263 0.0003
715 VIRAL INFECTION 11 0.0003
716 URINARY RETENTION 11 0.0003
717 NEOPLASM MALIGNANT 22 0.0003
718 RESPIRATORY FAILURE 24 0.0003
719 NEURALGIA 8 0.0003
720 GENERAL PHYSICAL HEALTH DETERIORATION 38 0.0003
721 JOINT INJURY 7 0.0003
722 RESPIRATORY DEPRESSION 4 0.0003
723 LIVER INJURY 8 0.0003
724 LYMPHOMA 5 0.0003
725 AGRANULOCYTOSIS 6 0.0003
726 HEPATIC ENZYME INCREASED 22 0.0003
727 CYST 4 0.0003
728 ERYTHEMA MULTIFORME 3 0.0003
729 APPENDICITIS 3 0.0003
730 FLANK PAIN 3 0.0003
731 SECRETION DISCHARGE 4 0.0003
732 CATARACT 19 0.0003
733 DERMATITIS ALLERGIC 4 0.0003
734 CYANOSIS 5 0.0003
735 FRACTURE 6 0.0003
736 ABDOMINAL PAIN LOWER 8 0.0003
737 MUSCLE ATROPHY 4 0.0003
738 RESPIRATORY TRACT CONGESTION 5 0.0003
739 HYPOTHYROIDISM 10 0.0003
740 ORAL PAIN 7 0.0003
741 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
742 POLLAKIURIA 13 0.0003
743 LYMPHADENOPATHY 11 0.0003
744 ATELECTASIS 3 0.0003
745 INFUSION SITE PAIN 4 0.0003
746 UNRESPONSIVE TO STIMULI 8 0.0003
747 EAR PAIN 6 0.0003
748 DYSSTASIA 9 0.0003
749 AUTOIMMUNE DISORDER 3 0.0003
750 PALPITATIONS 36 0.0003
751 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
752 SKIN DISCOLOURATION 14 0.0003
753 IMMUNE SYSTEM DISORDER 4 0.0003
754 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
755 SINUS DISORDER 6 0.0003
756 OXYGEN SATURATION DECREASED 17 0.0003
757 QUALITY OF LIFE DECREASED 4 0.0003
758 PRODUCT PHYSICAL ISSUE 6 0.0003
759 CORONARY ARTERY DISEASE 9 0.0003
760 ARRHYTHMIA 14 0.0003
761 OEDEMA 16 0.0003
762 BLINDNESS 12 0.0003
763 CIRCULATORY COLLAPSE 5 0.0003
764 AKATHISIA 4 0.0003
765 EAR DISCOMFORT 3 0.0003
766 MOBILITY DECREASED 21 0.0003
767 EYE DISCHARGE 3 0.0003
768 NERVOUS SYSTEM DISORDER 9 0.0003
769 COMPLETED SUICIDE 24 0.0003
770 ORAL DISCOMFORT 4 0.0003
771 HYPOAESTHESIA 43 0.0003
772 GASTROOESOPHAGEAL REFLUX DISEASE 23 0.0003
773 SKIN REACTION 4 0.0003
774 CYSTITIS 9 0.0003
775 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
776 RETCHING 6 0.0003
777 THIRST 5 0.0003
778 PERIPHERAL SWELLING 43 0.0003
779 LEUKOCYTOSIS 5 0.0003
780 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
781 RESTLESS LEGS SYNDROME 5 0.0003
782 ABDOMINAL DISCOMFORT 46 0.0003
783 LIP SWELLING 9 0.0003
784 RASH MACULO-PAPULAR 6 0.0003
785 IMMUNODEFICIENCY 4 0.0003
786 RESPIRATORY DISORDER 8 0.0003
787 OSTEOPOROSIS 11 0.0003
788 GASTRITIS 7 0.0003
789 NASOPHARYNGITIS 49 0.0003
790 HEPATIC FAILURE 8 0.0003
791 PANCREATITIS 14 0.0003
792 OSTEOPENIA 4 0.0003
793 TOXIC EPIDERMAL NECROLYSIS 4 0.0003
794 CARDIO-RESPIRATORY ARREST 11 0.0003
795 DEHYDRATION 35 0.0003
796 SEPSIS 29 0.0003
797 ORAL HERPES 5 0.0003
798 DIARRHOEA 165 0.0003
799 HYPERTENSION 54 0.0003
800 BLOOD PRESSURE ABNORMAL 5 0.0003
801 MUSCULOSKELETAL STIFFNESS 22 0.0003
802 WOUND 7 0.0003
803 INFECTION 36 0.0002
804 PYREXIA 86 0.0002
805 BLOOD POTASSIUM INCREASED 4 0.0002
806 THROAT IRRITATION 11 0.0002
807 HERPES ZOSTER 14 0.0002
808 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
809 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
810 CANDIDA INFECTION 4 0.0002
811 ABDOMINAL PAIN UPPER 48 0.0002
812 INFLAMMATION 12 0.0002
813 HYPOACUSIS 10 0.0002
814 SWELLING FACE 15 0.0002
815 MALAISE 101 0.0002
816 DEATH 196 0.0002
817 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
818 UNEVALUABLE EVENT 17 0.0002
819 HEPATOTOXICITY 5 0.0002
820 THROMBOSIS 18 0.0002
821 SNEEZING 5 0.0002
822 BLOOD PRESSURE INCREASED 34 0.0002
823 GINGIVAL BLEEDING 3 0.0002
824 HYPOTENSION 44 0.0002
825 HYPERHIDROSIS 28 0.0002
826 HYPOKALAEMIA 10 0.0002
827 BRONCHITIS 16 0.0002
828 INFLUENZA 24 0.0002
829 DEVICE OCCLUSION 3 0.0002
830 DISCOMFORT 13 0.0002
831 DISEASE RECURRENCE 10 0.0002
832 SKIN DISORDER 7 0.0002
833 BLOOD PRESSURE FLUCTUATION 5 0.0002
834 GLAUCOMA 4 0.0002
835 LIVER FUNCTION TEST ABNORMAL 6 0.0002
836 HAEMORRHOIDS 4 0.0002
837 KIDNEY INFECTION 4 0.0002
838 COLON CANCER 3 0.0002
839 BLOOD POTASSIUM DECREASED 6 0.0002
840 CYTOKINE RELEASE SYNDROME 4 0.0002
841 HAEMATOCHEZIA 11 0.0002
842 NEUTROPENIA 27 0.0002
843 PRURITUS 76 0.0002
844 COUGH 55 0.0002
845 CHEST DISCOMFORT 20 0.0002
846 OROPHARYNGEAL PAIN 18 0.0002
847 FEMUR FRACTURE 6 0.0002
848 RASH GENERALISED 5 0.0002
849 BLOOD CHOLESTEROL INCREASED 9 0.0002
850 SWOLLEN TONGUE 6 0.0002
851 URTICARIA 32 0.0002
852 MOUTH ULCERATION 4 0.0002
853 PRODUCTIVE COUGH 9 0.0002
854 BONE PAIN 11 0.0002
855 MENSTRUATION IRREGULAR 5 0.0002
856 BURNING SENSATION 13 0.0002
857 DYSPEPSIA 18 0.0002
858 BREAST CANCER 17 0.0002
859 STAPHYLOCOCCAL INFECTION 6 0.0002
860 LIVER DISORDER 8 0.0002
861 DRY EYE 9 0.0002
862 ARTHROPATHY 10 0.0002
863 TOOTH DISORDER 4 0.0002
864 MUSCLE SPASMS 33 0.0002
865 HEART RATE IRREGULAR 4 0.0002
866 EXTRA DOSE ADMINISTERED 7 0.0002
867 MYOCARDIAL INFARCTION 30 0.0002
868 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
869 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
870 GALLBLADDER DISORDER 3 0.0002
871 BACK PAIN 39 0.0002
872 CHEST PAIN 31 0.0002
873 LACRIMATION INCREASED 5 0.0002
874 BONE DISORDER 3 0.0002
875 FIBROMYALGIA 4 0.0002
876 CEREBRAL INFARCTION 4 0.0002
877 ANAEMIA 31 0.0002
878 CONJUNCTIVITIS 3 0.0002
879 DYSGEUSIA 12 0.0002
880 SWELLING 15 0.0002
881 INTESTINAL OBSTRUCTION 6 0.0002
882 DYSPNOEA 90 0.0002
883 ACUTE KIDNEY INJURY 24 0.0002
884 SINUSITIS 16 0.0002
885 NIGHT SWEATS 5 0.0002
886 RHINORRHOEA 10 0.0002
887 NASAL CONGESTION 9 0.0002
888 HAEMORRHAGE 16 0.0002
889 DEAFNESS 4 0.0002
890 ECZEMA 8 0.0002
891 SKIN IRRITATION 7 0.0002
892 EYE DISORDER 5 0.0002
893 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
894 FUNGAL INFECTION 5 0.0001
895 CARDIAC FAILURE 12 0.0001
896 STOMATITIS 9 0.0001
897 BODY TEMPERATURE INCREASED 3 0.0001
898 PNEUMONITIS 4 0.0001
899 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
900 ATRIAL FIBRILLATION 14 0.0001
901 ABDOMINAL DISTENSION 15 0.0001
902 NECK PAIN 8 0.0001
903 PLATELET COUNT DECREASED 15 0.0001
904 PRODUCT QUALITY ISSUE 19 0.0001
905 FLUID RETENTION 7 0.0001
906 ABDOMINAL PAIN 32 0.0001
907 NEUROPATHY PERIPHERAL 13 0.0001
908 DYSURIA 5 0.0001
909 BLOOD PRESSURE DECREASED 9 0.0001
910 MYALGIA 23 0.0001
911 ARTHRALGIA 56 0.0001
912 COLITIS ULCERATIVE 6 0.0001
913 GLOSSODYNIA 3 0.0001
914 PAIN IN EXTREMITY 39 0.0001
915 ACNE 10 0.0001
916 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
917 HEART RATE INCREASED 13 0.0001
918 RENAL IMPAIRMENT 11 0.0001
919 FEELING HOT 8 0.0001
920 INJECTION SITE RASH 4 0.0001
921 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
922 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
923 ARTHRITIS 10 0.0001
924 DISEASE PROGRESSION 15 0.0001
925 BLOOD GLUCOSE DECREASED 6 0.0001
926 DIABETIC KETOACIDOSIS 3 0.0001
927 EYE PAIN 7 0.0001
928 NEUTROPHIL COUNT DECREASED 5 0.0001
929 LUNG DISORDER 6 0.0001
930 ERYTHEMA 25 0.0001
931 INFLUENZA LIKE ILLNESS 10 0.0001
932 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
933 EPISTAXIS 9 0.0001
934 AGEUSIA 3 0.0001
935 DRY SKIN 16 0.0001
936 WITHDRAWAL SYNDROME 5 0.0001
937 PAIN 73 0.0001
938 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
939 HAEMATEMESIS 3 0.0001
940 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
941 VAGINAL HAEMORRHAGE 5 0.0001
942 SEPTIC SHOCK 5 0.0001
943 DEEP VEIN THROMBOSIS 7 0.0001
944 RENAL DISORDER 5 0.0001
945 HEPATIC FUNCTION ABNORMAL 4 0.0001
946 CARDIAC DISORDER 10 0.0001
947 ASTHMA 12 0.0001
948 COLITIS 4 0.0001
949 RENAL FAILURE 14 0.0001
950 OCULAR HYPERAEMIA 5 0.0001
951 DIABETES MELLITUS 8 0.0001
952 EYE IRRITATION 6 0.0001
953 ILL-DEFINED DISORDER 6 0.0001
954 PLEURAL EFFUSION 6 0.0001
955 LUNG NEOPLASM MALIGNANT 4 0.0001
956 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
957 GYNAECOMASTIA 3 0.0001
958 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
959 PULMONARY EMBOLISM 9 0.0001
960 JOINT SWELLING 11 0.0001
961 FLATULENCE 5 0.0001
962 GASTRIC DISORDER 3 0.0001
963 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
964 HYPOGLYCAEMIA 4 0.0001
965 C-REACTIVE PROTEIN INCREASED 3 0.0001
966 OEDEMA PERIPHERAL 10 0.0001
967 EYE SWELLING 3 0.0001
968 CHRONIC KIDNEY DISEASE 6 0.0001
969 PSORIASIS 10 0.0001
970 MUSCULOSKELETAL PAIN 4 0.0001
971 INFUSION RELATED REACTION 5 0.0001
972 FEBRILE NEUTROPENIA 5 0.0001
973 BLISTER 4 0.0001
974 SKIN BURNING SENSATION 5 0.0001
975 FLUSHING 7 0.0001
976 CHILLS 8 0.0001
977 HOT FLUSH 5 0.0001
978 EMOTIONAL DISTRESS 8 0.0001
979 BLOOD GLUCOSE INCREASED 12 0.0001
980 BLOOD CREATININE INCREASED 4 0.0001
981 SKIN EXFOLIATION 5 0.0001
982 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
983 PRODUCT STORAGE ERROR 5 0.0001
984 DEVICE MALFUNCTION 4 0.0001
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
986 DRUG DEPENDENCE 9 0.0001
987 CARDIAC FAILURE CONGESTIVE 4 0.0000
988 PROSTATE CANCER 4 0.0000
989 HAEMOGLOBIN DECREASED 5 0.0000
990 DRUG DOSE OMISSION 7 0.0000
991 INJECTION SITE PAIN 6 0.0000